Physician profile
Robert Williams
NPI 1982635173
$14,674.72
in general payments reported to CMS, 2019-2025
41 companies · $2,142 in 2025
The $2,142 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,049 · 2020: $1,697 · 2021: $2,757 · 2022: $1,949 · 2023: $1,627 · 2024: $1,454 · 2025: $2,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,128 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,127.87 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,912.94 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,549.65 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $1,243.21 | 2019-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $1,231.35 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,045.86 | 2019-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $990.65 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $784.91 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $704.04 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $620.36 | 2021-2025 | Zeposia |
| Bayer Healthcare Pharmaceuticals INC. | $578.32 | 2019-2025 | |
| Lilly USA, LLC | $515.73 | 2019-2024 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $421.65 | 2019-2020 | |
| Lundbeck LLC | $344.06 | 2021-2025 | Vyepti |
| Astellas Pharma US INC | $272.39 | 2023-2024 | Veozah |
| Horizon Therapeutics Plc | $265.90 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.